Evidence map›Paper›PMID 22276203›Full record

ArticlePloS one2012

Protein kinase D1 maintains the epithelial phenotype by inducing a DNA-bound, inactive SNAI1 transcriptional repressor complex.

Ligia I Bastea, Heike Döppler, Bolanle Balogun, Peter Storz

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Protein kinase D signaling in cancer: A friend or foe?Biochimica et biophysica acta. Reviews on cancer · 2017
    Review
  18. Article
  19. The regulation of snail: on the ubiquitin edge.Cancer cell & microenvironment · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ligia I BasteaDepartment of Cancer Biology, Mayo Clinic, Jacksonville, Florida, United States of America.
Heike Döppler
Bolanle Balogun
Peter Storz
Mayo Clinic in Florida · US

Funding

The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI PETER C LUCAS · 2005 to 2026
$49.9M
Protein Kinase D in oncogenic oxidative stress signalingR01CA140182 · NCI · MAYO CLINIC JACKSONVILLE · PI STORZ, PETER · 2010 to 2014
$1.5M
Role of Protein Kinase D in Actin Remodeling and Cell MotiliyR01GM086435 · NIGMS · MAYO CLINIC JACKSONVILLE · PI STORZ, PETER · 2010 to 2013
$1.1M
NCI NIH HHS CA116201-03DR4NCI NIH HHS CA140182NCI NIH HHS P50 CA116201NCI NIH HHS R01 CA140182NIGMS NIH HHS GM086438NIGMS NIH HHS R01 GM086435
6 · The paper itself

Abstract

backgroundProtein kinase D1 is downregulated in its expression in invasive ductal carcinoma of the breast and in invasive breast cancer cells, but its functions in normal breast epithelial cells is largely unknown. The epithelial phenotype is maintained by cell-cell junctions formed by E-cadherin. In cancer cells loss of E-cadherin expression contributes to an invasive phenotype. This can be mediated by SNAI1, a transcriptional repressor for E-cadherin that contributes to epithelial-to-mesenchymal transition (EMT). METHODOLOGY/PRINCIPAL

findingsHere we show that PKD1 in normal murine mammary gland (NMuMG) epithelial cells is constitutively-active in its basal state and prevents a transition to a mesenchymal phenotype. Investigation of the involved mechanism suggested that PKD1 regulates the expression of E-cadherin at the promoter level through direct phosphorylation of the transcriptional repressor SNAI1. PKD1-mediated phosphorylation of SNAI1 occurs in the nucleus and generates a nuclear, inactive DNA/SNAI1 complex that shows decreased interaction with its co-repressor Ajuba. Analysis of human tissue samples with a newly-generated phosphospecific antibody for PKD1-phosphorylated SNAI1 showed that regulation of SNAI1 through PKD1 occurs in vivo in normal breast ductal tissue and is decreased or lost in invasive ductal carcinoma. CONCLUSIONS/SIGNIFICANCE: Our data describe a mechanism of how PKD1 maintains the breast epithelial phenotype. Moreover, they suggest, that the analysis of breast tissue for PKD-mediated phosphorylation of SNAI1 using our novel phosphoS11-SNAI1-specific antibody may allow predicting the invasive potential of breast cancer cells.

Indexed as

AnimalsCadherinsCell LineCell Line, TumorChromatin ImmunoprecipitationDNADogsEpithelial CellsFemaleHumansImmunoblottingImmunoprecipitationIn Vitro TechniquesLIM Domain ProteinsMammary Glands, AnimalMiceajuba protein, mouseCadherinsDNALIM Domain ProteinsProtein Kinase Cprotein kinase DSNAI1 protein, humanSnai1 protein, mouseSnail Family Transcription FactorsTranscription Factors

Identifiers

PMID22276203
PMCPMC3262827
OpenAlexW1995905822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.